Simplex Trading’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-537
| Closed | -$1.01M | – | 8435 |
|
|
2019
Q3 | $1.01M | Buy |
537
+501
| +1,392% | +$5.73K | ﹤0.01% | 1924 |
|
|
2019
Q2 | $42K | Buy |
36
+17
| +89% | +$206 | ﹤0.01% | 5022 |
|
|
2019
Q1 | $25K | Buy |
19
+2
| +12% | +$26 | ﹤0.01% | 5576 |
|
|
2018
Q4 | $17K | Sell |
17
-20
| -54% | -$256 | ﹤0.01% | 5485 |
|
|
2018
Q3 | $61K | Buy |
37
+27
| +270% | +$488 | ﹤0.01% | 4980 |
|
|
2018
Q2 | $15K | Sell |
10
-193
| -95% | -$2.93K | ﹤0.01% | 6110 |
|
|
2018
Q1 | $16K | Buy |
203
+109
| +116% | +$1.58K | ﹤0.01% | 3594 |
|
|
2017
Q4 | $6K | Sell |
94
-41
| -30% | -$458 | ﹤0.01% | 4421 |
|
|
2017
Q3 | $11K | Sell |
135
-188
| -58% | -$1.96K | ﹤0.01% | 3732 |
|
|
2017
Q2 | $1K | Buy |
+323
| New | +$5.97K | ﹤0.01% | 5888 |
|
|
2017
Q1 | – | Sell |
-27
| Closed | -$4K | – | 7140 |
|
|
2016
Q4 | $4K | Sell |
27
-26
| -49% | -$676 | ﹤0.01% | 4639 |
|
|
2016
Q3 | $31K | Buy |
53
+39
| +279% | +$1.19K | ﹤0.01% | 2554 |
|
|
2016
Q2 | $2K | Sell |
14
-78
| -85% | -$2.11K | ﹤0.01% | 5094 |
|
|
2016
Q1 | $13K | Buy |
92
+83
| +922% | +$1.92K | ﹤0.01% | 3251 |
|
|
2015
Q4 | $9K | Sell |
9
-44
| -83% | -$1.49K | ﹤0.01% | 3446 |
|
|
2015
Q3 | $1K | Sell |
53
-19
| -26% | -$808 | ﹤0.01% | 5268 |
|
|
2015
Q2 | $37K | Buy |
+72
| New | +$2.62K | ﹤0.01% | 1940 |
|
Simplex Trading's ALDR Position: Q4 2019 in Review
Simplex Trading sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 12,198 shares — an estimated $230K sold.
Simplex Trading first reported a position in ALDR in Q2 2015 and held it in 16 quarters. The position peaked at $764K in Q3 2015. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Simplex Trading reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Simplex Trading sold 12,198 Alder Biopharmaceuticals shares in Q4 2019, an estimated $230K.
- Simplex Trading first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 16 quarters.
- Simplex Trading's Alder Biopharmaceuticals position peaked at $764K in Q3 2015.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Simplex Trading's 13F filing for Q4 2019, filed 5 Feb 2020.